2025 second_quarter Filing
Q2Income
$50K
Filed
July 21, 2025
Lobbying Activities
Budget/AppropriationsView all
Accelerated approval pathway; support for Alzheimer's diagnostics; obesity treatment.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Taxation/Internal Revenue CodeView all
International and domestic tax issues. OBBB.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Health IssuesView all
General education about policies impacting pharmaceutical development and approval. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention, 340B Program. Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
Lobbyists (8)
SUSAN HIRSCHMANN
mr MATTHEW B HOEKSTRA
KURT SCHRADER
Former Member of Congress
mr CHRISTOPHER W HATCHER